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The A-to-G transition mutation in the tRNALy” gene of mitochondrial DNA (mtDNA), characteristic for the maternally inherited MERRF 
syndrome (myoclonic epilepsy with ragged red fibers), has been identified by point mutation-specific polymerase chain reaction in extraocular 
muscle from I1 of 16 healthy people of different ages. No mutation was found in navel-string samples from 5 newborns, in HeLa cells, and in 2 
individuals younger than 20 years. On the other hand, the mutation is present in all 5 tested 7C89-year-old individuals and in 6 of 9 2&70-year-old 
individuals. The amount of mutated from total mtDNA was estimated by ‘mispairing PCR’ in extraocular muscle of 2 individuals of 74 and 89 
years to 2.0 and 2.4%. respectively. In most tissue samples the MERRF mutation occurs together with the ‘common deletion’ of mtDNA, which 
was previously shown to accumulate in healthy individuals with increasing age. It is proposed that during aging, deletions and point mutations 
of mtDNA accumulate, which could impalr mitochondrial energetics. 
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1. INTRODUCTION 
The MERRF syndrome (myoclonic epilepsy with 
ragged red fibers) is a maternally inherited encephalo- 
myopathy characterized by decreased activities of respi- 
ratory enzymes in skeletal muscle mitochondria [1,2]. 
Its molecular basis could be related to an A-to-G tran- 
sition mutation at nucleotide pair (np) 8,344 in the gene 
for tRNALy” of mitochondrial DNA (mtDNA) [3]. Re- 
sults on the incorporation of [35S]methionine into mito- 
chondrial proteins of cultured fibroblasts from 
MERRF patients have shown an impaired synthesis of 
enzyme complexes involved in respiration and oxidative 
phosphorylation [ 1,4], indicating an impaired function 
of the mutated tRNALy”. 
It has been proposed that somatic mutations of 
mtDNA during aging will decrease the capacity of en- 
ergy generation in tissues [5]. In addition it has been 
proposed that the final death of each individual is re- 
lated to the accumulation of statistic somatic mutations 
of mtDNA, in particular of the heart, due to the con- 
stant turnover of mtDNA also in non-dividing cells [6]. 
This proposal was based on the demonstration of focal 
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cytochrome c oxidase-defective cells in the heart [7] and 
in skeletal muscle fibres [8] with increasing age. By using 
the polymerase chain reaction (PCR), several recent 
publications have shown the occurrence of deletions of 
mtDNA in tissues of elderly people [9-151. These dele- 
tions have so far been described only in mtDNA from 
patients with mitochondrial myopathies without proven 
maternal inheritance, such as Kearns Sayre syndrome 
or CPEO (chronic progressive external ophthalmople- 
gia) [l&20]. In other patients with different forms of 
mitochondrial diseases lacking deleted mtDNA, point 
mutations of various mitochondrial tRNA genes have 
been described [21]. 
We have applied a point mutation-specific PCR (PS- 
PCR) to identify low contents of the A-to-G transition 
mutation at np 8,344 in mtDNA, characteristic for the 
maternally inherited MERRF syndrome, in healthy 
people of increasing age. This method uses a primer 
containing a mismatched 3’ residue, and corresponds to 
the ‘allele-specific PCR’ (ASPCR) [22-231 or the ‘ampli- 
fication refractory mutation system’ (ARMS) [24]. 
2. EXPERIMENTAL 
2.1. Preparation of DNA from human tissues 
Post mortem specimen of extraocular muscle and of skeletal muscle 
were obtained from human individuals of different ages, with no 
indications for a mitochondrial disease, between 3 and 19 h after 
death. Navel strings were obtained immediately after birth from the 
women’s hospital. Total DNA was extracted and purified according 
to Wallace et al. [1], followed by digestion of RNA with RNase A, and 
the amount was quantified spectrophotometrically. 
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2.2. PCR ampir$cafions 
PCR amplifications were carried out m 100 ~1 volumes with 100 ng 
total DNA of the indicated tissue, 200 PM of each dNTP (dATP, 
dCTP, dGTP, dTTP), 50 mM KCI, 10 mM Tris-HCl, pH 8.3, 1.5 mM 
MgC&, 0.01% (w/v) gelatine, and 30 pmol each of the forward primer, 
Pl (np 8.259-8.280 of the mtDNA sequence [25]: TACCCTATAG- 
CACCCCCTCTA), and the MERRF point mutation-specific reverse 
primer, P2 (np 8,369~8,344: CATTTCACTGTAAAGAGGTGTTG- 
GC). Primer P2 included at its 3’ end the mutated nucleotide and will 
amplify under selected conditions only the mutated mtDNA. After 5 
mm at 94°C (hot start) 1 U Taq polymerase (Amersham) was added. 
The reactions were carried out in a Perkin Elmer Cetus DNA thermal 
cycler by ‘touch down PCR’ [26], including l min each of denaturation 
at 94”C, elongation at 72°C. and annealing from 72 to 70°C during 
the first 3 cycles. and at 69°C for a further 30 cycles. 
Amplifications by ‘mispairing PCR’ [27] were performed with 10 ng 
total DNA with the Pl primer and the mispairmg P3 primer (np 
8,372~8,345: GGGGCATTTCACTGTAAAGAGGTGCCGG), in 
the presence of [a-“P]dATP. The mispairing primer is homologeous 
to the 5 region adjacent o the mutated nucleotide xcept for 2 nucle- 
otides which create a restriction site for Nael in the amplified fragment 
including the mutated nucleotide. The amplified fragments were pre- 
cipitated with ethanol, treated with Nael and separated on 8% poly- 
acrylamide gels. The gel was ilver stained for subsequent isolating and 
countmg of the bands. The ‘common deletion’ was amplified with the 
forward primer, Pi. and the reverse primer, P4 (np 13,795-13,774: 
TTAG~TAGAGGGGGA~GTTG). This primer pair. under the 
applied conditions, will only amphfy the region around the common 
deletion (np 8,482-13,459), resulting m a DNA fragment of 560 np 
[28]. The PCR was performed for 35 cycles after hot start at 94°C 
denaturation, 58°C annealing and 72°C elongation temperature for 
1 min each. From each reaction 5 ~1 were loaded on the 1% agarose 
gel. 
of the mutated mtDNA at np 8,344 in the presence of 
excess wild-type mtDNA, and obtained specific amplifi- 
cation under the following conditions: hot start (i.e. 
incubation without Tuq polymerase for 5 min at 94”(Z), 
touch down PCR [26], and annealing temperature of 
69°C. Under these conditions no amplification of the 
fragment of 111 np was obtained with 5 different navel- 
string DNA samples and with DNA from HeLa cells, 
as shown in Fig. 1. In contrast, with DNA from extraoc- 
ular muscle of 3 young and 8 elderly, and from skeletal 
muscle of 2 elderly people, the expected fragment was 
amplified under otherwise identical conditions. No am- 
plification was obtained with DNA of extraocular mus- 
cle from 3 young and 2 elderly and from skeletal muscle 
of 1 elderly individual. This result indicates the accumu- 
lation with increasing age of the MERRF mutation in 
mtDNA of muscle tissue. The lack of mutated mtDNA 
in some tissue samples from elderly people indicates 
either the absence, or too small amounts, of this muta- 
tion to be detected by our method. It should be pointed 
out that the mutated mtDNA was found in males as well 
as in females. 
To verify that the PCR-amplified bands represent he 
correct DNA fragment, the bands were electroeluted, 
digested with D&I and separated on 8% acrylamide 
gels. The expected double bands of 52 and 59 np size 
were obtained (not shown). 
3. RESULTS AND DISCUSSION 
We have systematically investigated the optimal con- 
ditions for specific ampli~cation of very small amounts 
In order to estimate the amount of mutated mtDNA, 
we amplified total mtDNA by mispairing PCR, which 
introduces a restriction site into the amplified DNA, 
and digested the amplified fragment with the restriction 
enzyme, NaeI, which cleaves only mutated mtDNA f27j. 
Navet-str. Eye muscle o. Eye muscle sk.mu. 
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Fig. 1. Point mutation-specific PCR of mtDNA from different issues of humans of variable age. The negative image of the ethidium bromide-stained 
1% agarose gel is shown. M, marker (HueHI-digested PhiX 174 DNA) with the fragment size on the right side in np: Navel-str. (lanes i-5). 
navel-string DNA from 5 different newborns; H, HeLa cell DNA; Eye muscle (lanes l-6), DNA of extraocular muscle of younger people (sex in 
brackets) aged 17, 18, 20, 20 cm), 24 (m). and 30 (0, respectively; o.Eye muscle (lanes I-10). DNA of extraocular muscle from old people aged 
67 (t),69 (m), 70 (0. 70 (m), 70 (0, 75 (fl,74 (m), 76 (m), 79 (m), and 89 (m), respectively; sk.mu. (lanes I-3). skeletal muscle DNA of individuaIs 
aged 67-72 years. 
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Fig. 2. Autoradiography of DNA fragments amplified by mispairing 
PCR and digested with the restriction endonuclease, NueI. The reverse 
image of the autoradiography is shown. Lane 1, navel-string DNA; 
lane 2, DNA of extraocular muscle (age 89, male); lane 3, DNA of 
extraocular muscle (age 74, male); lane 4, DNA of skeletal muscle 
from a MERRF patient (patient IV-2 of [4]). 
As shown in Fig. 2, no digestion of the amplified 114 
np fragment from navel-string DNA, but a small 
amount of digested DNA (88 np) from amplified extra- 
Navel-str. Eye muscle 
M12345-H-123456- 1 
Table I 
Content of mtDNA mutated at np 8,344 in individuals of different age 
and of a MERRF patient, as determined by mispairing PCR [27] 
Lane of Fig. 2 cpm % 
mutated 
Upper band Lower band mtDNA 
1 3,414 0 0 
2 817 16 2.4 
3 3,911 61 2.0 
4 2,603 5,657 73.6 
The silver-stained bands of 114 and 88 np size of Fig. 2 were cut out 
and counted in a scintillation counter. The % of mutated mtDNA was 
calculated based on the adenosine content of the fragments. 
ocular muscle DNA of 2 individuals, can be seen. In 
contrast, the amplified fragment from muscle DNA of 
a MERRF patient was largely digested by NueI (Fig. 2, 
lane 4). The amount of mutated mtDNA was quantified 
by counting the radioactivity of the cleaved and un- 
cleaved fragments, which had been labelled by [cx- 
32P]dATP during PCR. Table I shows that 2.4 and 2.0% 
of total mtDNA from extraocular muscle of 2 people, 
aged 89 and 74 years, respectively, were mutated at np 
8,344. No radioactivity was found at the corresponding 
position of 88 np in lane 1 of Fig. 2 to which navel-string 
DNA was applied. 
We have also investigated the common deletion of 
mtDNA, which is characteristic for some cases of 
Kearns Sayre Syndrome and CPEO [l&20], and which 
was shown to occur also in healthy humans with in- 
creasing age [9-151. In Fig. 3 is shown the amplified 
fragment of 560 np in most cases of extraocular muscles 
from elderly people but not from 17-30-year-old peo- 
ple, and not in skeletal muscle, HeLa cells and navel- 
string tissue. 
These results demonstrate that aging is also associ- 
ated, in addition to deletions of mtDNA, with point 
mutations in the tRNALy” gene of mtDNA, supporting 
the proposed accumulation of statistic somatic muta- 
tions of mtDNA with aging [5,6]. These mutations of 
mtDNA may contribute, in addition to other as yet 
unknown point mutations, to the defective respiratory 
o. Eye muscle sk.mu. 
2345678910-123-M 
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Fig. 3. PCR amplification of the region adjacent o the common deletion of mtDNA of various tissue samples. The negative image of the ethidium 
bromide-stained 1% agarose gel is shown. The same samples were applied to the indicated lanes as described in the legend to Fig. 1. 
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function of individual cells in aging tissue [7,8], and thus 
to the decrease of energetic capabilities of old people. 
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